Back to UBS Group AG UBS Group AG

CRDFCRDF
Showing 8 of 24 quarters

Position history for UBS Group AGUBS Group AG's holdings in CARDIFF ONCOLOGY INC

UBS Group AG holds 638,699 shares of CRDF (CARDIFF ONCOLOGY INC), worth $830,309 as of 2026-Q2. The position was increased (+59.5% shares). CRDF represents 0.0% of UBS Group AG's portfolio.

Current Value

$830,309

Current Shares

638,699

Total Value Change

+$700,643

Total Shares Change

+590,135

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
638,699
+59.5%
$830,3090.0%$1.30
36
2026-Q1
Increased
400,576
+358.2%
$648,9340.0%$1.89
39
2025-Q4
Decreased
87,429
-57.6%
$245,6750.0%$2.87
0
2025-Q3
Increased
206,175
+4.4%
$424,7210.0%$2.08
25
2025-Q2
Increased
197,438
+128.2%
$621,9300.0%$3.15
39
2025-Q1
Decreased
86,535
-69.5%
$271,7200.0%$3.29
0
2024-Q4
Increased
283,352
+483.5%
$1.2M0.0%$4.26
41
2024-Q3
Increased
48,564
+15.7%
$129,6660.0%$2.77
17

Other major holders of CRDF: RA CAPITAL MANAGEMENT, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used